The intrinsic links between chemerin and the ERK1/2 signaling pathway have been verified in a few pathological processes, including systemic hypertension, lipolytic metabolism and insulin resistance (Zhang et al., 2014; Fu et al., 2018; Jiang et al., 2018). The gene discussed is MAPK3; the disease is Insulin resistance.